Collagen platelet receptor polymorphisms integrin alpha 2 beta 1 C807T and GPVI Q317L and risk of ischemic stroke

VJ Cole, JM Staton, JW Eikelboom, GJ Hankey, Q Yi, Y Shen, MC Berndt, RI Baker

    Research output: Contribution to journalArticle

    38 Citations (Scopus)


    Several polymorphisms of integrin alpha2beta1 and glycoprotein (GP) VI that may modify platelet-collagen interactions or subsequent signaling have been described. We conducted a case-control study involving 180 stroke patients and 172 controls to determine whether the alpha2 C807T and GPVI Q317L polymorphisms were associated with an increased risk of ischemic stroke. We found no statistically significant differences in the distribution of alpha2 C807T and GPVI Q317L in patients and controls overall or after stratification by etiological subtype. The GPVI 317QQ genotype was found to be over-represented in a subgroup of patients greater than or equal to60 years compared to corresponding controls. However, this association did not remain significant after adjustment for other cardiovascular risk factors. Our results do not support a role for the integrin alpha2 C807T and GPVI Q317L polymorphisms in the development of first-ever ischemic stroke. However, larger studies are required to confirm this.

    Original languageEnglish
    Pages (from-to)963-970
    Number of pages8
    JournalJournal of Thrombosis and Haemostasis
    Issue number5
    Publication statusPublished - May 2003

    Cite this